Redx Pharma is a drug discovery and development company formed in 2010. It is focused on improving the characteristics of existing drug classes to create new drugs in the areas of cancer, immunology and infection. The company's work has been endorsed by partnerships with global pharmaceutical companies and the NHS.
Final Results for the year ended 30 September 2016
21 March 2017
Redx (AIM: REDX) announces its results for the year ended 30 September 2016: